2,178 results match your criteria: "K1H 8L6 Canada; McGill University[Affiliation]"
Injury
November 2024
University of Calgary, 0490 McCaig Tower, Foothills Hospital, 3134 Hospital Drive NW Calgary, Alberta, Canada T2N 5A1.
J Clin Epidemiol
December 2024
Centre for Studies in Family Medicine, Departments of Family Medicine and Epidemiology/Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Introduction: The pragmatic explanatory continuum indicator summary (PRECIS) tool, initially published in 2009 and revised in 2015, was created to assist trialists to align their design choices with the intended purpose of their randomised controlled trial (RCT): either to guide real-world decisions between alternative interventions (pragmatic) or to test hypotheses about intervention mechanisms by minimising sources of variation (explanatory). There have been many comments, suggestions, and criticisms of PRECIS-2. This summary will be used to facilitate the development of to the next revision, which is PRECIS-3.
View Article and Find Full Text PDFJPRAS Open
December 2024
Department of Plastic, Reconstructive, and Aesthetic Surgery, Geneva University Hospitals, Geneva University, 1205, Geneva, Switzerland.
Introduction: Radiotherapy is a challenge in autologous breast reconstruction because of its impact on cutaneous and vascular systems. Hyperbaric oxygen therapy (HBOT) is a recognized treatment of radiation-related complications. We aimed to assess the impact of perioperative HBOT on irradiated breast microvascular reconstructive outcomes.
View Article and Find Full Text PDFSubst Abuse Treat Prev Policy
September 2024
School of Public Health, University of Alberta, 3-300 ECHA, 11405- 87 Ave, Ave, Edmonton, AB, 11405-87, T6G 1C9, Canada.
Background: Examining support for substance use policies, including those for harm reduction, among the general public and policy influencers is a fundamental step to map the current policy landscape and leverage policy opportunities. Yet, this is a knowledge gap in Canada. Our paper identifies the level of support for substance use policies in two provinces in Canada and describes how the level of support is associated with intrusiveness and sociodemographic variables.
View Article and Find Full Text PDFVaccine
October 2024
Sinai Health System, 600 University Ave, Toronto, ON M5G 1X5, Canada; University of Toronto, 27 King's College Cir, Toronto, ON M5S 1A1, Canada. Electronic address:
Background: The demand for COVID-19 vaccines has diminished as the pandemic lingers. Understanding vaccine hesitancy among essential workers is important in reducing the impact of future pandemics by providing effective immunization programs delivered expeditiously.
Method: Two surveys exploring COVID-19 vaccine acceptance in 2021 and 2022 were conducted in cohorts of health care providers (HCP) and education workers participating in prospective studies of COVID-19 illnesses and vaccine uptake.
Int J Environ Res Public Health
August 2024
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 2A1, Canada.
People with schizophrenia have died at disproportionately higher rates during recent extreme heat events (EHEs) in Canada, including the deadly 2021 Heat Dome in British Columbia (B.C.).
View Article and Find Full Text PDFCurr Oncol
August 2024
Department of Medicine, Division of Medical Oncology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Concerns exist regarding increased toxicities, including endocrine therapy toxicity, with concurrent radiation and endocrine therapy in early breast cancer (EBC). We present a pragmatic, randomized trial comparing concurrent versus sequential endocrine and radiotherapy in hormone-responsive EBC. In this multicenter trial, patients were randomized to receive adjuvant endocrine therapy concurrent with, or sequential to, radiotherapy.
View Article and Find Full Text PDFCurr Oncol
July 2024
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1G 5Z3, Canada 2 Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada 3 Department of Medicine, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada 4 Royal Ottawa Mental Health Center, Ottawa, ON K1Z 7K4, Canada.
Hematologic cancers, notably leukemias and lymphomas, pose significant challenges to healthcare systems globally, due to rising incidence rates and increasing costs. This study aimed to estimate the phase and lifetime health system total costs (not net costs) of care for patients diagnosed with leukemia and lymphoma in Ontario, Canada. We conducted a population-based study of patients diagnosed between 2005 and 2019, using data from the Ontario Cancer Registry linked with health administrative databases.
View Article and Find Full Text PDFNat Commun
August 2024
Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
J Assist Reprod Genet
October 2024
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, ON, K1H 8L6, Canada.
Purpose: To compare fertility outcomes of obese patients (body mass index [BMI] ≥ 30 kg/m) undergoing superovulation and intrauterine insemination (SO-IUI) using gonadotropins versus letrozole.
Methods: A single centre retrospective cohort study of obese patients undergoing SO-IUI using gonadotropins or letrozole between January/2019 and June/2022. Primary outcome was clinical pregnancy rate (intrauterine pregnancy with positive fetal heart rate).
J Patient Rep Outcomes
August 2024
Takeda Pharmaceuticals USA Inc, Cambridge, MA, USA.
J Comp Eff Res
October 2024
Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada.
Diroximel fumarate (DRF), ozanimod (OZA) and interferon beta-1a (IFN) are disease-modifying therapies approved for the treatment of relapsing multiple sclerosis. No randomized trials have compared DRF versus OZA and IFN. We compared DRF versus OZA and DRF versus IFN using matching-adjusted indirect comparisons for efficacy outcomes, including annualized relapse rate (ARR), 12- and 24-week confirmed disability progression (CDP) and absence of gadolinium-enhancing (Gd+) T1 lesions and new/newly enlarging T2 lesions.
View Article and Find Full Text PDFMutat Res Genet Toxicol Environ Mutagen
August 2024
Environmental and Radiation Health Sciences Directorate, Health Canada, 775 Brookfield Road, PL 6303B, Ottawa, ON K1A 1C1, Canada. Electronic address:
In the event of a large-scale incident involving radiological or nuclear exposures, there is a potential for large numbers of individuals to have received doses of radiation sufficient to cause adverse health effects. It is imperative to quickly identify these individuals in order to provide information to the medical community to assist in making decisions about their treatment. The cytokinesis-block micronucleus assay is a well-established method for performing biodosimetry.
View Article and Find Full Text PDFThe EQUATOR (Enhancing the Quality and Transparency Of health Research) Network supports the practice of data sharing, and the reporting of data management and sharing plans, in all reports of biomedical research. Both practices should be included as checklist items when developing new or updating reporting guidelines. More focus should be given to structuring and standardising data management and sharing plans to help provide a similar impact as reporting guidelines.
View Article and Find Full Text PDFCancers (Basel)
July 2024
Division of Gastroenterology, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Pancreatic cancer has one of the worst prognoses among all malignancies and few available treatment options. Patient-derived xenografts can be used to develop personalized therapy for pancreatic cancer. Endoscopic ultrasound fine-needle aspiration (EUS-FNA) may provide a powerful alternative to surgery for obtaining sufficient tissue for the establishment of patient-derived xenografts.
View Article and Find Full Text PDFSemin Arthritis Rheum
October 2024
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Canada; University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada. Electronic address:
J Neurooncol
September 2024
Division of Medical Oncology, Department of Medicine, University of Ottawa and the Ottawa Hospital, Ottawa, ON, K1H 8L6, Canada.
Purpose: Pneumocystis jirovecii pneumonia (PJP) prophylaxis is required by provincial and national drug monographs during glioma treatment using temozolomide (TMZ) concurrently with radiation (TMZ-RT). However, real-world data suggest the potential benefits of PJP prophylaxis may not outweigh its potential harms in this population.
Methods: We conducted a single-center patient survey and a national physician survey to explore the role of PJP prophylaxis amongst glioma patients undergoing TMZ-RT.
Syst Rev
August 2024
Ottawa Hospital Research Institute, 501 Smyth Road, Box 201B, Ottawa, ON, K1H 8L6, Canada.
Background: Cancer treatment-related cognitive impairment (CTRCI) can substantially reduce the quality of life of cancer survivors. Many treatments of CTRCI have been evaluated in randomized controlled trials (RCTs), including psychological interventions, pharmacologic interventions, and other therapies. There is a pressing need to establish the benefits and harms of previously studied CTRCI treatments.
View Article and Find Full Text PDFBreast Cancer Res Treat
December 2024
Division of Medical Oncology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
Purpose: While adjuvant bisphosphonate use in early breast cancer (EBC) is associated with improvements in breast cancer-specific outcomes, questions remain around optimal bisphosphonate type, dose and scheduling. We evaluated a single zoledronate infusion in a prospective randomised trial.
Methods: Postmenopausal patients with EBC were randomised to receive a single infusion of zoledronate (4 mg IV) or 6-monthly treatment for 3 years.
J Hip Preserv Surg
July 2024
Division of Orthopaedic Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, Ontario K1H 8L6, Canada.
The association between preoperative pain catastrophizing and postoperative patient-reported outcome measures of patients with pre-arthritic hip disease was evaluated. All patients scheduled for joint-preserving surgeries of the hip (JPSH) at our institution were approached. Patient demographics (age, sex, body mass index (BMI)), pain intensity (Numeric Pain Scale (NPS)) and pain catastrophizing (Pain Catastrophizing Scale (PCS)) were collected preoperatively.
View Article and Find Full Text PDFNurs Clin North Am
September 2024
The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.
For maximum effectiveness of a simulation-based educational experience, the correct modality must be chosen. Modality refers to the equipment or platform used to conduct the simulation. There are a variety of options available to clinical simulation educators, ranging from simple task trainers to full-body manikins to virtual experiences.
View Article and Find Full Text PDFToxics
June 2024
Department of Biology, Faculty of Science, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Glyoxalase 1 (Glo1) is an essential enzyme to detoxify methylglyoxal (MGO), a cytotoxic byproduct of glycolysis. Accumulating studies have shown an important role of Glo1 in regulating cortical development and neurogenesis, potentially contributing to the pathogenesis of autism spectrum disorder (ASD) when impaired. We have previously shown that prenatal exposure to non-apoptotic low-dose methylmercury (MeHg), an environmental pollutant, induces premature cortical neurogenesis and ASD-like behaviors in a rodent model.
View Article and Find Full Text PDFCurr Oncol
June 2024
The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Most patients diagnosed with and dying from cancer in Canada are older adults, with aging contributing to the large projected growth in cancer incidence. Older adults with cancer have unique needs, and on a global scale increasing efforts have been made to address recognized gaps in their cancer care. However, in Canada, geriatric oncology remains a new and developing field.
View Article and Find Full Text PDFRadiographics
August 2024
Department of Radiology, Radiation Oncology and Medical Physics, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Medical Imaging, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, Canada K1H 8L6; and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.